Loading
Latest filing published 29 Jul 2026 for 신테카바이오. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 정종선 in 신테카바이오, where the filings describe the role as chief executive. The record holds 68 filings, for trades running from 12 July 2021 to 29 July 2026.
In open-market terms, that means 43 purchases on one side and 8 sales on the other. The amount is not disclosed for 51 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 10 purchases and no sales.
No cluster: in 28 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 29 July 2026, reports a transaction in 신테카바이오. The last purchase on record was published on 29 July 2026, which is 81 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 68 declarations